tradingkey.logo
搜尋

Prenetics Global Ltd

PRE
添加自選
15.850USD
-1.740-9.89%
交易中 美東報價延遲15分鐘
204.37M總市值
虧損本益比TTM

Prenetics Global Ltd

15.850
-1.740-9.89%
查看詳細走勢圖
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-9.89%

5天

-0.13%

1月

-11.99%

6月

+29.92%

今年開始到現在

+0.63%

1年

+173.48%

TradingKey Prenetics Global Ltd股票評分

單位: USD 更新時間: 2026-05-14

操作建議

Prenetics Global Ltd當前公司基本面數據相對穩定,最新ESG揭露屬於行業領先水平。增長潛力很大。當前估值合理,在生物技術與醫療研究行業排名117/382位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為31.25。中期看,股價處於下降通道。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Prenetics Global Ltd評分

相關信息

行業排名
117 / 382
全市場排名
233 / 4482
所屬行業
生物技術與醫療研究

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
中性

Prenetics Global Ltd亮點

亮點風險
Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients. The Company is also engaged in consumer health products by a new health and wellness brand IM8.
業績高增長
公司營業收入穩步增長,連續3年增長324.92%
業績增長期
公司處於發展階段,最新年度總收入92.39M美元
估值低估
公司最新PE估值-4.24,處於3年歷史低位
機構減倉
最新機構持股1.76M股,環比減少30.62%
詹姆斯·西蒙斯持倉
明星投資者詹姆斯·西蒙斯持倉,最新持倉16.92K股
活躍度降低
近期活躍度降低,過去20天平均換手率1.06

分析師目標

基於 2 分析師
買入
評級
31.250
目標均價
+77.86%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Prenetics Global Ltd新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Prenetics Global Ltd簡介

Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients. The Company is also engaged in consumer health products by a new health and wellness brand IM8.
公司代碼PRE
公司Prenetics Global Ltd
CEOKwok (Samantha)
網址https://ir.prenetics.com/
KeyAI